yohimbine has been researched along with quin2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, GH; White, JG | 1 |
| Arkhammar, P; Berggren, PO; Nilsson, T; Rorsman, P | 1 |
2 other study(ies) available for yohimbine and quin2
| Article | Year |
|---|---|
Aspirin, prostaglandin E1 and Quin-2 AM-induced platelet dysfunction: restoration of function by noradrenalin.
Topics: Adult; Alprostadil; Aminoquinolines; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Calcium; Cell Membrane; Humans; Norepinephrine; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Adrenergic, alpha; Yohimbine | 1990 |
Inhibition of glucose-stimulated insulin release by alpha 2-adrenoceptor activation is parallelled by both a repolarization and a reduction in cytoplasmic free Ca2+ concentration.
Topics: Adrenergic alpha-Agonists; Aminoquinolines; Animals; Calcium; Clonidine; Cytoplasm; Diazoxide; Female; Glucose; Insulin; Male; Membrane Potentials; Mice; Ouabain; Potassium; Yohimbine | 1988 |